ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,619, issued on April 29, was assigned to GENENTECH INC. (South San Francisco, Calif.).
"Modulating lactogenic activity in mammalian cells" was invented by Shahram Misaghi (South San Francisco, Calif.), Masaru Ken Shiratori (South San Francisco, Calif.), Bradley Richard Snedecor (South San Francisco, Calif.) and Michael W. Laird (South San Francisco, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods, cells and compositions for producing a product of interest, e.g., a recombinant protein. In particular, the present disclosure provides improved mammalian cells expressing the product of interests, where the c...